Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The authors acknowledge that GLP-1 agonists have "shown substantial benefits" for many ... Beyond movement, they explain, ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

First, they provide structure and function and are essential for ... With the widespread use of glucagon-like peptide 1 (GLP-1) receptor agonist drugs, which are very effective at shedding weight ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

Certain GLP-1 medications, like Ozempic ... kinesiology and physiology at Pennsylvania State University who studies energy ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Patients in the semaglutide group also had a greater improvement in their physical function score on the 36 ... [of anti-inflammatory effects] that GLP-1 agonist drugs may have." ...